Agilent Technologies, Inc.
A Healthcare Diagnostics & Research
Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow A
Agilent Technologies, Inc. (A) EV/FCF
As of 16 October 2026, Agilent Technologies, Inc. (A) trades at a EV/FCF of 39.9×. Over the past ten years it has ranged from 19.6× (October 2016) to 57.3× (May 2015); the current reading is higher than 84% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 37.1× | 27.73% |
| FY2024 | 29.1× | 35.53% |
| FY2023 | 21.4× | (49.30%) |
| FY2022 | 42.3× | 11.98% |
| FY2021 | 37.8× | (9.11%) |
| FY2020 | 41.5× | 48.71% |
| FY2019 | 27.9× | 25.07% |
| FY2018 | 22.3× | (24.26%) |
| FY2017 | 29.5× | 39.58% |
| FY2016 | 21.1× | (26.58%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jul 2026 | 32.2× | 3.77% |
| Apr 2026 | 31.1× | (21.96%) |
| Jan 2026 | 39.8× | 7.26% |
| Oct 2025 | 37.1× | 17.52% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| DGX Quest Diagnostics Incorporated compare | 23.1× |
| IQV IQVIA Holdings Inc. compare | 25.8× |
| LH Labcorp Holdings Inc. compare | 30.8× |
| IDXX IDEXX Laboratories, Inc. compare | 36.0× |
| A Agilent Technologies, Inc. | 39.9× |
| MTD Mettler-Toledo International, Inc. compare | 40.2× |
| ILMN Illumina, Inc. compare | 44.1× |
| WAT Waters Corporation compare | 129× |
| NTRA Natera, Inc. compare | 658× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on A
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement